US · Healthcare

THC Therapeutics Inc (THCT)

Drug Manufacturers - Specialty & Generic

THC Therapeutics Inc (THCT) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for THCT

P/E ratio

18.00

THC Therapeutics Inc (THCT) — FAQ

What is THCT's P/E ratio?

The price-to-earnings (P/E) ratio for THC Therapeutics Inc (THCT) is 18.00 (data as of 2026-05-23).

Does THC Therapeutics Inc pay a dividend?

Dividend yield is not available in the current snapshot for THC Therapeutics Inc (THCT). Check the MyAverix Finance app for the latest dividend data.

What sector is THC Therapeutics Inc in?

THC Therapeutics Inc (THCT) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is THCT listed on?

THCT is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)